To analyze the important elements for retroviral expression in hepatocytes, cis-acting elements in the U3 region of the long terminal repeat (LTR) of the polycythemic strain of spleen focus-forming virus (SFFVp) were analyzed in a hepatocellular carcinoma cell line. Two cis-acting elements located within the upstream region of the direct repeat, which positively regulated retroviral expression, were identified. Transcription factors NFAT5 and Sp1, which are ubiquitously expressed in a variety of tissues, bound to these elements. To increase specificity without lowering the potency of retroviral expression in hepatocytes, these elements were replaced by a sequence derived from the hepatitis B virus enhancer II region. Novel vectors, SF-Hep3 and SF-Hep5 (SFFVp-based vector for hepatocytes 3 and 5), were developed with these engineered LTRs. The engineered LTRs of these vectors enhanced the retroviral expression only in hepatocellular carcinoma cell lines in vitro. These vectors also increased transgene expression 4-to 9-fold or 3.5-to 5-fold in comparison with a Moloney murine leukemia virus-based vector or a vector containing the wild-type LTR of SFFVp, respectively, in murine hepatocytes in vivo.
INTRODUCTION
Retroviral vectors are the most commonly used vehicles for stable gene transfer into various cell types. These vectors can integrate into the host genome to provide longterm transgene expression in the target cells [1, 2] . Hepatocytes are attractive targets for these vectors, since they synthesize a myriad of proteins that play pivotal roles in metabolism or hemostasis. One of the major limitations to the use of retroviral vectors in hepatocytes is the low level of transgene expression [3, 4] .
cis-acting elements located in the U3 region of the retroviral long terminal repeats (LTRs) determine mainly the transcriptional level of newly introduced genes in target cells. Most of the cis-acting elements are found within the direct repeat (DR) [5] [6] [7] [8] [9] [10] . In addition to in the DR, the elements were also identified in the upstream control region (UCR; the upstream region of the DR) [11] [12] [13] [14] . Although these elements were proven to regulate retroviral expression, the activities of these elements have been analyzed in detail mainly in hematopoietic or embryonic cells and not in hepatocytes.
The polycythemic strain of spleen focus-forming virus (SFFVp) is a replication-incompetent virus related to Friend mink cell focus-forming viruses [15] . Its LTR provides high transgene expression in primitive hematopoietic cells [16, 17] and spermatogenic cells [18] . Recently, we have demonstrated that the SFFVp U3 also provides about fourfold stronger retroviral enhancer activity than that of the Moloney murine leukemia virus (MoMLV) in hepatocytes in vivo [19] . In the present study, we have analyzed the regulatory elements of the SFFVp LTR in a hepatocellular carcinoma cell line and an attempt has been made to enhance its promoter activity especially in hepatocytes.
RESULTS AND DISCUSSION

Strong cis-Acting Elements Are Located in the Upstream Region of the DR in SFFVp
To localize the region important for high retroviral expression within the SFFVp U3, we constructed a series of reporter gene plasmids containing the sequence from the SFFVp U3 (Fig. 1A) . We used a well-differentiated human hepatocellular carcinoma cell line, PLC/PRF/5 [20] , for transient reporter assays, since the results of reporter assays in cultured PLC/PRF/5 cells correlated well with those in hepatocytes in vivo [19] . pSF418luc contains the sequence from position Ϫ4 (4 bp upstream of the cap site) to Ϫ418. Deletion of more than 56 bp from the 5Ј end significantly reduced the activities (pSF352luc, pSF322luc, or pSF289luc in Fig. 1A ), indicating the presence of cisacting elements in the upstream region of the DR (the UCR). We constructed another series of reporter gene plasmids, which contain a series of 3Ј to 5Ј deletions from position Ϫ178 (Fig. 1B) . Deletion of the UCR (the region between Ϫ371 and Ϫ303) reduced the activities to half of that of pSF418luc (pSF371-311/178luc or pSF371-320/ 178luc in Fig. 1B ), confirming the enhancer activity in the UCR.
To analyze the important elements, we cloned the fragment of the U3 from position Ϫ371 to Ϫ303 into another reporter gene plasmid, pTKluc, containing a thymidine kinase promoter of the herpes simplex virus. This fragment showed enhancer activity regardless of orientation (Fig. 1C, p371-303TKluc and p303-371TKluc) . Further analysis showed that the sequences from Ϫ362 to Ϫ343 and from Ϫ320 to Ϫ303 were sufficient to enhance the activity (Fig. 1D) .
Taken together, these results clarified the enhancer activity of the UCR in SFFVp U3 and that the activity was localized to two regions, spanning from Ϫ362 to Ϫ343 and from Ϫ320 to Ϫ303.
Deletion of the Enhancer Elements from Retroviral Vectors Reduces Transgene Expression
To test whether these regions are also crucial for retroviral expression after integration into the genome, we generated a series of retroviral vectors that carry a chloramphenicol acetyltransferase (CAT) gene as a reporter. We produced retrovirus vectors using Phoenix-ampho cells and infected PLC/PRF/5 cells with these vectors. We selected cells in the presence of G418 and measured expression of CAT protein. Although the average numbers of proviral DNAs of SF/CATwt, SF/CAT⌬362-343, SF/ CAT⌬320-303, and SF/CAT⌬362-343/320-303 in the pooled cells were not significantly different (1.29, 1.27, 1.25, and 1.46, respectively), the expression levels from the enhancer-deleted vectors (SF/CAT⌬362-343, SF/ CAT⌬320-303, and SF/CAT⌬362-343/320-303) were almost equal to one another and were about half of that from SF/CATwt, which contains the full-length LTR (Fig.  2B) . These results confirmed the importance of these two regions for retroviral expression.
Mutation Analysis of the cis-Regulatory Elements in the UCR
We performed substitution mutation analysis to identify important regulatory elements. We scanned the regions from -362 to -343 and from -320 to -303 using a series of reporter gene plasmids, pMut/1 to pMut/10 (Fig. 3A) . Luciferase activities were significantly reduced by the mutation within the region from Ϫ358 to Ϫ347 or from Ϫ313 to Ϫ306, while no significant effect was observed with the flanking mutations (Fig. 3A) , indicating that the sequences of GGCATGGAAAAA and GGGCGGGT were crucial for the cis activity.
The first sequence, GGCATGGAAAAA, is well conserved among murine retroviruses and is located in the 3Ј flanking region of the binding motif for YY-1 (Fig. 3B) . The other sequence, GGGCGGGT, is located in the 5Ј flanking site of the DR, overlapping the Sp1 binding site [11] , and is not conserved between viruses (Fig. 3B) .
We have identified these elements located in the UCR and these elements have been proved to be crucial for retroviral expression. On the other hand, there might be some other elements located in regions other than the UCR (i.e., the DR or the 3Ј flanking region of the DR) that are also crucial for retroviral expression. Such elements remain to be clarified for our further understanding of high promoter activity of the SFFVp LTR in hepatocytes.
The Nuclear Factor of Activated T Cells 5 (NFAT5) Transcription Factor Binds to the UCR and Enhances Reporter Gene Expression
One of the identified regions (the position from Ϫ358 to Ϫ347) contains the GGA core motif for NFAT [21] and the substitution mutation analysis showed a clear preference for the sequence longer than the core motif, which contains the target motif for NFAT5 (PuTGGAAAnA) [24] . Since the expression of NFAT5, but not NFAT1, NFAT2, nor NFAT3, was detected by RT-PCR in PLC/PRF/5 cells (data not shown), we analyzed the binding ability of NFAT5 to this region. We transfected pCMV/flag-NFAT5, which contains human NFAT5 cDNA tagged by flag sequences (Fig. 4A) , into HEK293T cells and used nuclear extracts for electrophoretic mobility shift assays. One of by adding 100-times excess of unlabeled oligonucleotides or anti-flag antibody, respectively, indicating that NFAT5 protein bound to this sequence.
Next, we examined whether the exogenously expressed NFAT5 increased the expression of a reporter gene. Expression of NFAT5 increased the promoter activity of the SFFVp U3 in HEK293T cells (Fig. 4C) . Another reporter plasmid, p362-343x4TKluc, which contained four repeats of the sequence corresponding to position Ϫ362 to Ϫ343, was also transfected with pCMV/flag-NFAT5 (Fig. 4D ). The transfection of pCMV/flag-NFAT5 increased the luciferase activity in a dose-dependent manner, indicating that NFAT5 could enhance the retroviral expression.
NFAT5 belongs to the NFAT family of transcription factors and has also been designated as a tonicity enhancer binding protein, TonEBP [22] . Functional analysis of this protein, TonEBP/NFAT5, has clarified that it is induced upon hyperosmotic stimuli and is a target of integrin signaling [23] . Here we showed its potential to bind to the UCR of murine retroviruses and positively regulate their expression.
Engineering of the UCR Enhances the Reporter Gene Expression in Hepatocellular Carcinoma Cell Lines in Vitro
We have identified two regions important for retroviral expression. The first one contains a target of NFAT5 and the second one is known to be a target of Sp1 [11] . Since these transcription factors are expressed ubiquitously in a variety of tissues, but not restricted to hepatocytes [24, 25] , we made an attempt to examine whether the replacement of these target sequences increases specificity without lowering potency of retroviral expression in hepatocytes.
Hepatitis B virus (HBV) predominantly infects hepatocytes and the HBV genes are expressed specifically in liver, controlled by the combined action of the promoters and enhancers. The transcription of the viral mRNAs is regulated by two HBV enhancers, Enhancer I (EnI) and EnII, and the latter shows strong hepatocyte specificity [26, 27] . We replaced two regions within the SFFVp U3 with the sequences from HBV EnII (specified as "a" or "b" in Fig.  5A ), which determine the strong hepatocyte specificity and contain the targets of C/EBP, HNF4, HNF3, and HNF1. As shown in Fig. 5B , LTRs of pSF/Hep3-luc and pSF/Hep5-luc especially showed significantly higher promoter activity than the SFFVp LTR in PLC/PRF/5 cells (P Ͻ 0.005, Fig. 5B ).
We generated two retroviral vectors, SF-Hep3/CAT and SF-Hep5/CAT, which contained the LTRs from pSF/Hep3-luc and pSF/Hep5-luc, respectively (Fig. 6A) . First, we examined the efficiencies of the viral production of these novel vectors. Using Phoenix-eco packaging cells, titers of SF-Hep3/CAT and SF-Hep5/CAT were 5.7 ϫ 10 5 and 6.0 ϫ 10 5 G418-resistant colony-forming units per milliliter on NIH/3T3 cells (CFU-G418/ml), respectively, and were comparable with that of SF/CATwt (6.7 ϫ 10 5 CFU-G418/ ml). Next, we examined the activities of these engineered enhancers upon stable integration into the genome in cultured cells using Phoenix-ampho or -eco packaging cells. After the infection by these vectors at a multiplicity of infection lower than 0.1, we selected cells in the presence of G418 and measured expression of CAT protein.
Although the average copy numbers of the proviral DNAs were not significantly different (data not shown), SFHep5/CAT provided a higher CAT value than SF/CATwt in human hepatocellular carcinoma cells PLC/PRF/5, HLE [33] , and HuH-7 [34] . SF-Hep3/CAT provided a higher CAT value than SF/CATwt in PLC/PRF/5 and HLE cells (Fig. 6A) . On the other hand, CAT values were not increased in fibroblastic cells (NIH/3T3 and HEK293) or lymphoid cells (Jurkat). In a hematopoietic precursor cell line, K562, the values were lower than those obtained with SF/CATwt. These results showed that transgene expression was enhanced by the engineered LTRs only in hepatocellular carcinoma cells.
The Novel Vectors SF-Hep3 and SF-Hep5 Efficiently Express a Transgene in Murine Hepatocytes in Vivo
To test whether the engineered LTRs provide a high transgene expression in vivo, we infused mice with SF/CATwt, SF-Hep3/CAT, SF-Hep5/CAT, or a MoMLV-based vector, MO3/CAT [19] (Fig. 6B) , after partial hepatectomy. First, transgene expression was compared among these vectors 4 days after infusion. LTRs of SF/CATwt, SF-Hep3/CAT, and SF-Hep5/CAT were from SFFVp, pSF/Hep3-luc, and pSF/Hep5-luc, respectively. Expression of CAT by SF/ CATwt, SF-Hep3/CAT, or SF-Hep5/CAT was about 2.5-, 4-, or 9-fold higher, respectively, than that by the MoMLVbased vector, MO3/CAT, and SF-Hep5/CAT provided about 3.5-fold higher expression than SF/CATwt (Fig. 6C) . Since a partial hepatectomy induces liver cell replication, we additionally compared transgene expression among these vectors after 1 month of infusion to evaluate the expression in quiescent hepatocytes. Expression of CAT by SF/CATwt, SF-Hep3/CAT, or SF-Hep5/CAT was about 1.6-, 4.5-, or 5-fold higher, respectively, than that by MO3/CAT, and both SF-Hep3/CAT and SF-Hep5/CAT provided about 3-fold higher expression than SF/CATwt (Fig. 6D) .
These results indicated strongly improved expression of a transgene by engineered LTRs in hepatocytes in vivo. Thus, we developed novel vectors designated SF-Hep3 and SF-Hep5 (SFFVp-based vector for hepatocytes), which will provide high transgene expression in hepatocytes in vivo.
To increase the transgene expression in hepatocytes in vivo, we have compared the promoter activities of murine retroviruses [19] and engineered the LTR from SFFVp in this study. An alternative approach to increasing the expression is to use hepatocyte-specific internal promoters. Although both positive and negative influences can be transmitted between the LTR and such an internal promoter [28] , it has been proven that the use of the ␣1-antitrypsin promoter or the ApoE enhancer-␣1-antitrypsin promoter increased transgene expression in hepatocytes in vivo [29, 30] . Intensive effort has also been put into the development of viral vectors based on adenoassociated virus [31] and lentiviruses [32] . Together with the development of these vectors, the novel vectors designated SF-Hep3 and SF-Hep5 will provide a useful tool in the field of experimental hepatology, as well as important mechanistic information for the development of vectors for liver-targeted gene therapy.
MATERIALS AND METHODS
Cell lines. The human hepatocellular carcinoma cell lines PLC/PRF/5 [20] , HLE [33] , and HuH-7 [34] ; fibroblastic cell lines HEK293 and HEK293T; and hematopoietic cell lines K562 and Jurkat were maintained in DMEM supplemented with 10% fetal calf serum. A murine fibroblastic cell line, NIH/3T3, was maintained in DMEM with 10% calf serum. Amphotropic and ecotropic retrovirus packaging cell lines Phoenix-ampho and Phoenixeco (kindly provided by Dr. G. P. Nolan of Stanford University Medical Center, Stanford, CA) [35] , respectively, were cultured in DMEM with 10% fetal calf serum.
Construction of reporter gene plasmids.
A series of luciferase reporter gene vectors, schematically shown in Fig. 1A , was constructed as follows. The U3 region of SFFVp (corresponding to the sequences from 4 to 418 bp upstream of the cap site; position Ϫ4 to Ϫ418) was amplified by polymerase chain reaction and was ligated into the EcoRV site of pBlueScript SK (pBS; Stratagene, La Jolla, CA) by the TA cloning technique. A BamHIHindIII fragment was excised and ligated into BglII-HindIII sites of the promoterless firefly luciferase reporter gene vector pGL3-Basic (Promega Japan, Tokyo), to obtain pSF418luc. Using the same strategy, pSF371luc, pSF352luc, pSF320luc, pSF289luc, pSF272luc, pSF238luc, pSF228luc, pSF178luc, and pSF118luc were constructed, which contain the U3 sequences from position Ϫ4 to Ϫ371, Ϫ352, Ϫ320, Ϫ289, Ϫ272, Ϫ238, Ϫ228, Ϫ178, and Ϫ118, respectively. A series of luciferase reporter gene vectors, schematically shown in Fig. 1B , was constructed as follows. A fragment of the SFFVp U3 (position Ϫ320 to Ϫ371) was amplified, ligated into pBS, excised as an XbaI-XhoI fragment, and ligated into NheI-XhoI sites of pSF178luc to obtain pSF371-320/178luc. Using the same strategy, pSF371-311/178luc, pSF371-303/178luc, pSF371-270/178luc, pSF371-253/ 178luc, and pSF371-208/178luc were constructed, which contain the sequences from position Ϫ311, Ϫ303, Ϫ270, Ϫ253, or Ϫ208 to Ϫ371, respectively. A series of reporter gene plasmids, schematically shown in Fig.  1C , was constructed as follows. A BglII-HindIII fragment of the thymidine kinase promoter of herpes simplex virus from pRL-TK (Promega Japan) was ligated into BglII-HindIII sites of pGL3-Basic to obtain a plasmid, pTKluc. A fragment containing the SFFVp U3 (position from Ϫ303 to Ϫ362) was amplified, ligated into pBS (pBS362-303), excised as a XbaI-XhoI fragment, and ligated into NheI-XhoI sites of pTKluc to obtain p362-303TKluc. Using the same strategy, p371-311TKluc, p371-303TKluc, and p352-303TKluc were obtained, which contain the sequences from position Ϫ371 to Ϫ311, from Ϫ371 to Ϫ303, and from Ϫ352 to Ϫ303, respectively. Plasmid p303-371TKluc was obtained from a fragment containing the sequence from Ϫ303 to Ϫ371 in the direction opposite to p371-303TKluc. A series of reporter gene plasmids, schematically shown in Fig. 1D , was constructed as follows. Plasmid DNA of pBS362-303 was amplified by PCR, phosphorylated, self-ligated (pBS362-343/320-303), excised as an XbaI-XhoI fragment, and ligated into NheI-XhoI sites of pTKluc to obtain p362-343/320-303TKluc. Using the same strategy, p371-352/320-303TKluc and p371-343/320-303TKluc were obtained, in which the sequence from position Ϫ351 to Ϫ321 or from Ϫ342 to Ϫ321, respectively, was deleted. The sequence from position Ϫ352 to Ϫ371 or from Ϫ303 to Ϫ320 was further deleted from p371-352/320-303TKluc or p362-343/320-303TKluc to obtain p320-303TKluc or p362-343TKluc, respectively. All these plasmids were sequenced before the experiments. A reporter gene plasmid containing tandem repeats of the cis-regulatory element is schematically shown in Fig. 4D . The following pair of oligonucleotides was annealed, ligated into the EcoRV site of pBS, excised as an XbaI-XhoI fragment, and ligated into NheI-XhoI sites of pTKluc to obtain p362-343ϫ4TKluc, which contains four tandem repeats of the sequence from position Ϫ343 to Ϫ362: 5Ј-GCAAGGCATGGAAAAATACCGCAAGGCATGGAAAAATACCGCAAG-GCATGGAAAAATACCGCAAGGCATGGAAAAATACC-3Ј and 5Ј-GGTAT-TTTTCCATGCCTTGCGGTATTTTTCCATGCCTTGCGGTATTTTTCCATG-CCTTGCGGTATTTTTCCATGCCTTGC-3Ј.
FIG. 6. Comparison of CAT gene expression among retroviral vectors in vitro and in vivo.
Each column and bar represents the mean value and standard deviation of three assays, respectively. Significant difference (*P Ͻ 0.05 and **P Ͻ 0.01) from the value by SF/CATwt or MO3/CAT is indicated. (A) Retroviral vector plasmids were transiently transfected into Phoenix-ampho cells and the supernatants were used to transduce cell lines in vitro. wt, original sequence of the SFFVp UCR; a, b, replaced by the sequence indicated as boxed a or b (Fig. 5A ) from HBV EnII, respectively. (B) Retroviral vector plasmids carrying a CAT gene are schematically shown. A MoMLV-based retroviral vector plasmid, pMO3/CAT, contains the LTR and the leader sequences from MoMLV [19] . FMEV-type retroviral vector plasmids, pSF/CATwt, pSF-Hep3/CAT, and pSF-Hep5/CAT, contain the wild-type or engineered LTRs of the SFFVp and the leader sequences from mouse embryonic stem cell virus (MESV) [16] . These plasmids were transiently transfected into Phoenix-eco cells and the supernatants were used to transduce hepatocytes in vivo. (C) The liver was removed 4 days after infusion. The concentration of CAT protein was normalized to the concentration of total proteins (pg/mg), further normalized to the proportion of integrated proviral DNA (%), and represented as "normalized CAT/integration (pg/mg/%)." Integration efficiencies of proviral DNAs into the liver ranged from 0.07 to 0.39% in this experiment. MO3/CAT, n ϭ 3; SF/CATwt, n ϭ 3; SF-Hep3/CAT, n ϭ 3; SF-Hep5/CAT, n ϭ 3. (D) The liver was removed 1 month after infusion. Integration efficiencies of proviral DNAs into the liver ranged from 0.10 to 0.49% in this experiment. MO3/CAT, n ϭ 4; SF/CATwt, n ϭ 4; SF-Hep3/CAT, n ϭ 3; SF-Hep5/CAT, n ϭ 4.
Construction of reporter gene plasmids for mutation analysis of the cis-regulatory elements.
A series of reporter gene plasmids, schematically shown in Fig. 3A , was constructed as follows. The three to four base pair substitution mutations (A 3 G, T 3 C, C 3 T, G 3 A) were sequentially introduced from 5Ј to 3Ј into pBS362-343/320-303 using the Quick Change mutagenesis kit. After sequencing, an XbaI-XhoI fragment was excised and ligated into NheI-XhoI sites of pTKluc to obtain pMut/1 to pMut/10.
Construction of a plasmid for the expression of NFAT5. A human NFAT5 cDNA was amplified by reverse transcriptase-polymerase chain reaction from human liver cDNA and ligated into BamHI-XhoI sites of a mammalian expression vector, pCMV-Tag2 (Stratagene), to obtain pCMV/flag-NFAT5.
Construction of retroviral vector plasmids. The U3 region of the 5Ј LTR of pSF1N was replaced by a human cytomegalovirus promoter to obtain pSF1N/CMV. A plasmid DNA of pBS/LTR was amplified, self-ligated, excised, and ligated into BamHI-XhoI sites of pSF/CMV to generate pSF1N/ ⌬362-343, pSF1N/⌬320-303, or pSF1N/⌬362-343/320-303. A NotI-NotI fragment containing a CAT gene at the 5Ј position and internal ribosomal entry site from poliovirus was ligated into a NotI site of pSF/CMV, pSF1N/ ⌬362-343, pSF1N/⌬320-303, or pSF1N/⌬362-343/320-303 to obtain pSF/ CATwt, pSF/CAT⌬362-343, pSF/CAT⌬320-303, or pSF/CAT⌬362-343/320-303, respectively. Construction of pMO3/CAT was described elsewhere [19] .
Construction of plasmids containing engineered LTRs.
A series of reporter gene plasmids or retroviral vector plasmids containing the engineered LTRs is schematically shown in Fig. 5B or 6A , respectively. A BamHI-XhoI fragment containing the 3Ј LTR was ligated into pBS and plasmid DNA was amplified by PCR and ligated with annealed oligonucleotides (a) 5Ј-TTA-CATAAGAGGACTCTTGGACTCA-3Ј and 5Ј-TGAGTCCAAGAGTCCTCT-TATGTAA-3Ј or (b) 5Ј-ACTGTGTGTTTAAGGACTGGGAGGAGCTA-3Ј and 5Ј-TAGCTCCTCCCAGTCCTTAAACACACAGT-3Ј. SpeI-XhoI or BamHIXhoI fragments containing engineered LTRs were ligated into NheI-XhoI sites of pGL3-basic or BamHI-XhoI sites of pSF/CATwt to obtain pSF/Hep1-luc to pSF/Hep8-luc or pSF-Hep3/CAT and pSF-Hep5/CAT, respectively. Transient transfection and reporter gene assays. For transient reporter assays, 10 g of firefly luciferase reporter gene vector DNAs was cotransfected with pRL-CMV or pRL-TK (a Renilla luciferase vector; Promega Japan) DNA by calcium phosphate coprecipitation method as described [18] . Transfected cells were harvested after 48 h of incubation and luciferase activities were measured according to the Promega protocols and applications guide by using the Dual-Luciferase Reporter Assay System (Promega Japan) with the Turner Designs luminometer Model TD-20/20 (Promega Japan). The firefly luciferase activity of each lysate was normalized to the activity of Renilla luciferase and was represented as activity relative to that of pSF418luc, pTKluc, or p362-343/320-303TKluc. In some experiments, plasmids for the expression of transcription factors were additionally transfected into cells.
Production of retroviral vectors. Phoenix-ampho or Phoenix-eco cells were transfected with retroviral vector plasmids. After 2-5 days of culture, supernatant containing viral vectors was used in this study. Viral vectors were termed SF/CATwt, SF/CAT⌬362-343, SF/CAT⌬320-303, SF/CAT⌬362-343/320-303, MO3/CAT, SF-Hep3/CAT, or SF-Hep5/CAT to distinguish them from the corresponding plasmids.
Retroviral transduction and measurement of CAT protein and copy numbers of integrated proviral DNAs. Cells were infected with SF/CATwt, SF/CAT⌬362-343, SF/CAT⌬320-303, SF/CAT⌬362-343/320-303, SF-Hep3/ CAT, or SF-Hep5/CAT and were selected in the presence of G418 for 2 weeks. After selection, cells consisting of more than 100 different clones were lysed and the concentration of CAT protein of each lysate was measured by using a CAT enzyme-linked immunosorbent assay kit (Boehringer Mannheim GmbH, Mannheim, Germany). The concentration of CAT protein in each lysate was normalized to the concentration of total proteins (pg/mg) and was represented as CAT activity relative to that of SF/CATwt. To confirm that the copy numbers of integrated proviral DNAs in pooled cells were not significantly different among the vectors, TaqMan real-time PCR was performed after genomic DNAs were isolated from the samples. Genomic DNAs from clones containing one or two proviral integrations were used as standards. The estimated numbers were further normalized to ␤-actin using the following primers and probes: CAT primers, 5Ј-GTTTTCATCGCTCTGGAGTGAA-3Ј, 5Ј-CACGCCACATCTTGC-GAATATA-3Ј; CAT probe, 5Ј-CCACGACGATTTCCGGCAGTTTCTAC-3Ј; mouse ␤-actin primers, 5Ј-AAGAGCTATGAACTGCCTGACG-3Ј and 5Ј-CAAGAAGGAAGGCTGGAAAAGA-3Ј; mouse ␤-actin probe, 5Ј-CCCCTC-CCCAGTAAAGGCTTCTGTAGAGAG-3Ј; human ␤-actin primers; and a probe, TaqMan ␤-actin detection reagents kit (PE Applied Biosystems Japan, Tokyo).
In vivo experiments were performed as described previously [19] . In brief, virus particles were produced using Phoenix-eco packaging cells and were concentrated [36] . Forty-eight hours after partial hepatectomy, C57/ BL6 mice were infused via the tail vein with viruses representing infusion of 3-5 ϫ 10 6 G418-resistant colony-forming units on NIH/3T3 cells. Four days or 1 month after infusion, the liver was removed and the concentration of CAT protein in each lysate was normalized to the concentration of total proteins (pg/mg). Genomic DNAs from the samples were isolated and the proportions of the genomic integration of proviral DNAs were estimated by the TaqMan real-time PCR method. A genomic DNA from a NIH/3T3 clone containing a single integrated copy and that from an uninfected clone were mixed at a ratio ranging from 1:1000 to 1:10 and were used as standards. The estimated proportion was normalized to ␤-actin to determine the integration efficiencies (%). Normalized concentration of CAT protein of each sample (pg/mg) was further normalized to the integration efficiency (%) and was represented as normalized CAT/ integration (pg/mg/%) in Figs. 6C and 6D.
Western blotting and gel mobility shift assays. After the transfection of pCMV/flag-NFAT5 into HEK293T cells, cell lysate was analyzed by Western blot using an antibody to flag (M2; Sigma, St. Louis, MO). Preparations of nuclear extracts and gel mobility shift assays were performed as previously described [11] . The following set of oligonucleotides was annealed and used for this study: GGCAAGGCATGGAAAAATAC and GGTATTTTTC-CATGCCTTGC. Supershift assays using an antibody to flag (M2; Sigma) were performed by incubating antibodies with nuclear extract for 1 h at 4°C.
